INTRODUCTION
The variable clinical expression of sickle cell anemia has initiated a world-wide search for bioReceived for publication 10 September 1979 and(I in revised forn 7 November 1979. 732 chemical, hemiiatological, or enIvir-oinmental facwtors that mayi influenice the severity of the illniess. There is a wvidely held opinion that elevation of fretal hemoglobin (Hb-F)m or lowered erythrocyte imeaiii corpuscular volume (MCV) is associated wvith a clecreased severity of cliniical miianjifestationis and(I ain increase(l survival. This paper reports the restilts of a statistical assessmiient of the relationship between the hematological factors and(l the imortality anid morbidity of 214 patienits with sickle cell aniemiiia.
Backgroundil (of stU(lld. The concept that ele\vation of Hb-F favorably influenices morbidity has support froml both biochemlical ancd clinical stuidies (1) . Thuts, increased proportionis of Hl-F increase the minimnium gelling concenitration of mixttures of hemnoglobinis S andl F (2, 3), modify the polyvnerization kinetics (4, 5) , and increase the delay timiie to polymiierizationi in S-F mixtures (3, 6) . Hb-F is (lecrease(l in irreversibly sickle(d SS cells (7) and greater numilbers of irreversibly sickle(d SS cells produice increased viscosity of oxygenatedl whole SS bloo(d (8) . However, the kinetics of Hb-S polymerizationi suggest that the variable clinical expressioni inay ressult from several kinetic paths to polymerization anid to imiarginal changes in free energy (9) . \Miale et al. (10) have shown irregular shifts of Hb-F contenit amiiong the indlividual erythrocytes an(l have attempted to demonstrate a correlationi of this shift with growth and(I developmnent of the SS patient. Moreover, accordIinig to Dover et al. (11) , wide variationi exists in the pro(luctioni anid survival of F cells in persoius wVith sickle cell aniemlia.
Those persoins with the determinianit for the hereditary persistence of Hb-F in the tratns position to S have essentially, anl asymlptomiiatic condition (12, 13) . Further support for the concept that Hh-F is protective has come from observations of sickle cell anemia in several populationis (14) (15) (16) (17) (18) (19) (20) . In these populations the miiean Hb-F was high (10-25%), although within each population the range was wide (a few to 40%). The universal suggestion has been that the relatively mild expression of sickle cell anemia in these populationis is caused by the high Hb-F. Following Lehmann's observations (21) that sickle cell anemiiia appeared to be a less severe disease in vestern Africa where a-thalassemia is frequent, it has beein postulated that a-thalasseiiiia anid( sickle cell anemiiia in the same individual will protect the SS patient because of lowered MCV or mean corpuscular henmoglobin concenitration (MICHC) (22, 23 Statistical mtietho(ds. The seven clinical parameters were studied in two categories. The first categorv provided measures of imorbiditv through inmultiple occurrences of sickle cell crisis, acute chest syndrome, and hospital admission. Each paramneter in this group was analyzed using both multiple regressioni and discriininant analysis techniques (31) . The seconid categorv of clinical parameters included cerebrovascular accidenit, aseptic necrosis, mneningitis/septicemia, andl death. The first occurrence of these clinical parameters, which often significantly changes the subsequent course of the patient, was analyzed by survival analysis techmiiquies (32, 33) . In the mutltiple regression analysis, the dependenit variable is the risk of the recurrent clinical event, defined as the ntumber of episodes per person-year of observation or rate of occurrence. The independent variables are age at entry and the laboratory parameter under studv.
In the discrimiiniant analysis, strata of each laboratory paramiieter were used. Cut points of the strata were chosen either to separate normal from abnormal levels, or to divide the paraimieter into equal groups with high, medium, and lov values. The dependent variable in the analysis was the laboratory paramiieter and the indepenident variables were age at entry anod the risk of the clinical parameter as defined above. In view of the marked effect of age on clinical imianifestation (34), age at entry was "forced" into the (liscrilninant eqiuation to adjust for differences in average age at entry amnonig the strata defined by each laboratory parameter.
The survival analysis also used strata of the laboratory parameters as in the discrimiiinant analysis. The analysis compare(d the risk of the clinical parameter, defined as the probability of "terminiation" by the first occurrence of the cliniical event, among patients in different strata. Here, "terminination" refers to the end point of the patient's observation for that particular event under analysis. The log rank test wvas used in the survival analysis to determine statistical significance among the strata (35) .
Fetal Hemoglobitn anid Sickle Cell Antemia Fig. 3 . Table II summarizes the risk of sickle cell crisis, chest syndrome, and hospital admission in terms of frequency of episodes per person-year observed, and the risk of stroke, aseptic necrosis, meningitis/septicemia, and death in terms of the cumulative probability of termination by the first occurrence of these episodes at various ages.
Statistical analysis. No significant differences were observed in the multiple correlations of the risk of the clinical parameters with age at entry and the laboratory parameters. Neither the partial correlation of the laboratory parameter with risk, given age at entry, nor of age at entry with risk, given the laboratory parameter, was significant. The maximum value of the square of the multiple correlation coefficient, which measures the goodness-of-fit of the analysis, was found to be <3%. Thus, no laboratory parameter was found FIGURE 1 The frequency distribution of the percentage of FIGURE 2 The frequency distribution of MCV what lower than our mean percent Hb-F of 12.3±7.0, the methodologies for Hb-F determination were different. In general, alkaline denaturation methods as used in Jamaica and Turkey give lower readings particularly at higher levels (above 20%) of Hb-F so that these apparent differences may not be significant. Wrightstone and Huisman (43) reported a mean Hb-F (alkaline denaturation) of 6.6% in 117 Black SS individuals.
The strongest support for the concept that a high level of Hb-F ameliorates the severity of sickle cell disease comes from the ongoing reports of Arabian sickle cell anemia patients (14) (15) (16) (17) (18) (19) . Their mean Hb-F among 183 children was 25% and among 54 adults was 24%. Nevertheless, 95% of their SS cases covered a range of 12 to 40% Hb-F whereas in our group 40% of the cases fall within this range. As reported by Perrine et al. (18) , the Arabian SS cases show considerable variability of clinical expression. Information is not currently available regarding the correlation of risk of sickle crisis, stroke, chest syndrome, etc., and Hb-F levels in the Arabian SS population. Note that 75% of the Arabian SS patients were less than 20 yr of age when reported (18) , including many adolescent patients, an age range in which sickle cell anemia tends to be mnost quiescent in its manifestations. The 15 mildly affected Indian SS patients had characteristics much like those of the Saudi Arabians; the age ranige was from 8 to 26 yr and only two were >20 (20) .
Some of our S-only cases as well as those observed by others (18, 19) If it is correct that a decreased level of Hb-F increases the risk of stroke, then this briefly describeci hypothesis may explain why Hb-F levels, but none of the other indicators of morbiditv, do influence the risk of stroke. In sickle cell anemia the distorted damaged erythrocvte must be a factor in stroke. As 
